Simon C. Pedder
Founder of Chelsea Therapeutics International Ltd., Simon C. Pedder is a businessperson who has been at the helm of 6 different companies is Chief Business & Strategy Officer at Athenex, Inc. and on the board of 5 other companies.
In the past he was President, Chief Executive Officer & Director at Cellectar BioSciences, Inc. and Chief Executive Officer & Director at Novelos Therapeutics, Inc. (a subsidiary of Cellectar BioSciences, Inc.), President & Chief Executive Officer at Chelsea Therapeutics, Inc., President & Chief Executive Officer at Chelsea Therapeutics International Ltd., President & Chief Executive Officer at Ivory Capital Corp., Vice President-Pharmaceutical Business & Oncology at Hoffmann-La Roche, Inc. and Vice President-Drug Development at Shearwater Corp.
Simon C. Pedder received an undergraduate degree from The University of Waterloo, a graduate degree from Concordia University and a doctorate from the University of Saskatchewan College of Medicine.
Transactions
| 08/27/2019 | 6,734 | Acquisition at $2.98 per share. | 20,067 |
| 05/24/2019 | 250,000 | Award at $0 per share. | 0 |
| 05/14/2019 | 6,000 | Acquisition at $5.06 per share. | 30,360 |
